OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight
Mahmoud R. Hussein
British Journal of Dermatology (2005) Vol. 153, Iss. 1, pp. 18-21
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Darryl A. Oble, Robert Loewe, Ping Yu, et al.
PubMed (2009) Vol. 9, pp. 3-3
Closed Access | Times Cited: 186

Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma
Femke Hillen, Coen I.M. Baeten, Anouk van de Winkel, et al.
Cancer Immunology Immunotherapy (2007) Vol. 57, Iss. 1, pp. 97-106
Open Access | Times Cited: 117

Targeting Melanoma with Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors
Romina Marone, Dominik Erhart, Ann C. Mertz, et al.
Molecular Cancer Research (2009) Vol. 7, Iss. 4, pp. 601-613
Open Access | Times Cited: 113

DNA‐methylation profiling distinguishes malignant melanomas from benign nevi
Kathleen Conway, Sharon N. Edmiston, Zakaria Khondker, et al.
Pigment Cell & Melanoma Research (2011) Vol. 24, Iss. 2, pp. 352-360
Open Access | Times Cited: 85

Chemokines: key players in cancer progression and metastasis
Raj Singh
Frontiers in Bioscience-Scholar (2011) Vol. S3, Iss. 1, pp. 1569-1569
Open Access | Times Cited: 63

Peritumoral indoleamine 2,3‐dioxygenase expression in melanoma: an early marker of resistance to immune control?
Inès Chevolet, Reinhart Speeckaert, Marc Haspeslagh, et al.
British Journal of Dermatology (2014) Vol. 171, Iss. 5, pp. 987-995
Closed Access | Times Cited: 60

Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma
Teresa C. Longoria, Krishnansu S. Tewari
Expert Opinion on Drug Metabolism & Toxicology (2016) Vol. 12, Iss. 10, pp. 1247-1253
Open Access | Times Cited: 60

Mass spectrometric proteomics profiles ofin vivo tumor secretomes: Capillary ultrafiltration sampling of regressive tumor masses
Chun‐Ming Huang, Honnavara N. Ananthaswamy, Stephen Barnes, et al.
PROTEOMICS (2006) Vol. 6, Iss. 22, pp. 6107-6116
Closed Access | Times Cited: 70

Regulatory T cells and toll-like receptors: regulating the regulators
Roger P.M. Sutmuller, Anja Garritsen, Gosse J. Adema
Annals of the Rheumatic Diseases (2007) Vol. 66, Iss. Supplement 3, pp. iii91-iii95
Open Access | Times Cited: 69

The density and type of MECA‐79‐positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma
G Avram, Beatriz Sánchez‐Sendra, J.M. Martín, et al.
Histopathology (2013) Vol. 63, Iss. 6, pp. 852-861
Closed Access | Times Cited: 47

Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay, Page C. Moore, Bruce R. Smoller, et al.
Human Pathology (2011) Vol. 42, Iss. 12, pp. 1960-1964
Closed Access | Times Cited: 45

Checkpoints and beyond – Immunotherapy in colorectal cancer
Tobias Gutting, Elke Burgermeister, Nicolai Härtel, et al.
Seminars in Cancer Biology (2018) Vol. 55, pp. 78-89
Closed Access | Times Cited: 37

Tumour‐infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3+ and CD20+ lymphocytic populations
Ilaria Porcellato, Serenella Silvestri, Laura Menchetti, et al.
Veterinary and Comparative Oncology (2019) Vol. 18, Iss. 3, pp. 370-380
Open Access | Times Cited: 31

Synthesis and Pharmacological Evaluation of Selective Histone Deacetylase 6 Inhibitors in Melanoma Models
Maurício T. Tavares, Sida Shen, Tessa Knox, et al.
ACS Medicinal Chemistry Letters (2017) Vol. 8, Iss. 10, pp. 1031-1036
Open Access | Times Cited: 28

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment
Chiara Camisaschi, Viviana Vallacchi, Chiara Castelli, et al.
Expert Review of Molecular Diagnostics (2014) Vol. 14, Iss. 6, pp. 643-646
Closed Access | Times Cited: 26

Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF–Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content
Ronald J.C.L.M. Vuylsteke, Barbara G. Molenkamp, Paul A.M. van Leeuwen, et al.
Clinical Cancer Research (2006) Vol. 12, Iss. 9, pp. 2826-2833
Open Access | Times Cited: 37

Lentigines, nevi, and melanomas
David Weedon
Elsevier eBooks (2010), pp. 709-756.e61
Closed Access | Times Cited: 29

Melanoma vaccines: The problems of local immunosuppression
Marta E. Polak, Nicola Borthwick, Martine J. Jager, et al.
Human Immunology (2009) Vol. 70, Iss. 5, pp. 331-339
Closed Access | Times Cited: 28

Role of IL‐10 and TGF‐β in melanoma
Arlina Permatasari Wiguna, Peter Walden
Experimental Dermatology (2015) Vol. 24, Iss. 3, pp. 209-214
Open Access | Times Cited: 22

The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients
Katarina Mirjačić Martinović, Gordana Konjević, Nada Babović, et al.
Journal of Surgical Research (2010) Vol. 171, Iss. 2, pp. 637-649
Closed Access | Times Cited: 23

Pathobiological features of breast tumours in the State of Kuwait: a comprehensive analysis
Farid Saleh, Suad Abdeen
Journal of Carcinogenesis (2007) Vol. 6, Iss. 1, pp. 12-12
Open Access | Times Cited: 26

Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo
Hiroko Toyota, Noriko Yanase, Takayuki Yoshimoto, et al.
Oncology Reports (2014) Vol. 33, Iss. 1, pp. 292-296
Open Access | Times Cited: 15

Drug-induced skin reactions: a pathologist viewpoint
Mahmoud R. Hussein
Cutaneous and Ocular Toxicology (2015) Vol. 35, Iss. 1, pp. 67-79
Closed Access | Times Cited: 13

Effects of the Tumor Microenvironment on the Efficacy of Tumor Immunotherapy
Paul J. Neeson, Yvonne Paterson
Immunological Investigations (2006) Vol. 35, Iss. 3-4, pp. 359-394
Closed Access | Times Cited: 19

Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi's sarcoma
Mahmoud R. Hussein
Cell Biology International (2007) Vol. 32, Iss. 1, pp. 157-162
Closed Access | Times Cited: 15

Page 1 - Next Page

Scroll to top